Detection of distant metastatic disease by positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma.
Alexander J LinSirui MaFarrokh DehdashtiStephanie MarkovinaJulie SchwarzBarry SiegelMatthew PowellPerry GrigsbyPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2019)
Distant metastatic disease detected by FDG-PET is found in 6.2% of patients with cervical cancer at the time of initial diagnosis and the most common site of disease is the lung. Further prospective investigation is warranted to delineate best treatment practices for cervical cancer patients presenting with distant metastases.